ArticleInternational journal of molecular sciences2025

Hepatic Histopathological Benefit, Microbial Cost: Oral Vancomycin Mitigates Non-Alcoholic Fatty Liver Disease While Disrupting the Cecal Microbiota.

Gül Çirkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.